Wu, OH
Anchuu Wu, Broadview Heights, OH US
Patent application number | Description | Published |
---|---|---|
20110195035 | Ester Compounds For Use In Personal Care Products - The present invention relates to cosmetic and/or personal care formulations and/or compounds. In one embodiment, the present invention relates to ester compounds that can be used in various personal care formulations and/or compounds. In another embodiment, the present invention relates to branced ester compounds having a molecular weight of at least about 1,500 daltons that can be used in various personal care formulations and/or compounds. | 08-11-2011 |
20150218312 | Branched Polymeric Emulsifiers - The present invention relates to esterified glycerylated alkyl glycoside and to a process for making same. The esterified glycerylated alkyl glycoside have one or more polyglyceryl moieties and one or more acyl moieties, wherein all of the one or more acyl moieties are situated on the one or more polyglyceryl moieties via an ester linkage. These compounds have been found to be useful as emulsifiers and coemulsifiers in the formulation of a phase stable emulsions suitable for use in personal care, home care, industrial and institutional, and health care applications. | 08-06-2015 |
Chieh-Chun Wu, Cleveland, OH US
Patent application number | Description | Published |
---|---|---|
20130122393 | FUEL CELL SYSTEM WITH INTERCONNECT - In some examples, a fuel cell comprising a first electrochemical cell including a first anode and a first cathode; a second electrochemical cell including a second anode and a second cathode; an interconnect configured to conduct a flow of electrons from the first anode to the second cathode; and a chemical barrier. The chemical barrier may be configured to prevent or reduce material migration between the interconnect and at least one component (e.g., an anode) in electrical communication with the interconnect, where the chemical barrier includes doped strontium titanate. | 05-16-2013 |
Chien Hung Wu, Strongsville, OH US
Patent application number | Description | Published |
---|---|---|
20100258348 | INTERCONNECT AND SYSTEM INCLUDING SAME - An interconnect. The interconnect includes a thermal isolation structure and a layer of conductive material which covers the thermal isolation structure. The thermal isolation structure has a first end, a second end, and a sidewall. | 10-14-2010 |
20130279538 | Thermal Sensor Having a Coupling Layer, and a Thermal Imaging System Including the Same - A thermal sensor includes a first semi-transparent electrode; a second electrode; a thermally sensitive element positioned between the first and second electrodes; and a coupling layer positioned between the first electrode and the thermally sensitive element, wherein the thermally sensitive element is in electrical communication with the first electrode via the coupling layer and is in electrical communication with the second electrode. An optional second coupling layer may be positioned between the second electrode and the thermally sensitive element, wherein the thermally sensitive element is in electrical communication with the second electrode via the second coupling layer. | 10-24-2013 |
Chunying Wu, Beachwood, OH US
Patent application number | Description | Published |
---|---|---|
20120093727 | COMPOSITIONS AND METHODS FOR IN VIVO IMAGING OF MYELIN IN THE PERIPHERAL NERVOUS SYSTEM - A method of detecting and/or labeling myelin in an animal's peripheral nervous system tissue includes administering to the animal a fluorescent stilbenzene derivative and visualizing the animal's peripheral nervous system tissue using an in vivo imaging modality. | 04-19-2012 |
Chunying Wu, Mayfield Heights, OH US
Patent application number | Description | Published |
---|---|---|
20090123373 | AMYLOID-IMAGING AGENTS - A molecular probe for use in the detection of amyloid in a subject includes a dibenzothiazole derivative. | 05-14-2009 |
20100221180 | IN VIVO IMAGING OF MYELINATION - A molecular probe for labeling myelin includes a fluorescent stilbenzene derivative. | 09-02-2010 |
20110189090 | MOLECULAR PROBES FOR IMAGING OF MYELIN - A molecular probe for labeling myelin includes a fluorescent trans-stilbene derivative. | 08-04-2011 |
Haifeng M. Wu, Columbus, OH US
Patent application number | Description | Published |
---|---|---|
20080206787 | Process to determine enzyme activity - The present invention provides for various processes for determining enzyme activity. In one embodiment, a process for detecting an enzyme activity includes contacting a blood component with a substrate comprising a cleavage site of the enzyme and a tag moiety to produce a sample comprising a cleavage product having a known mass, and placing the sample in contact with a SELDI sample chip which has surface moieties which bind to the cleavage product. In another embodiment, the process further includes subjecting the SELDI sample chip to SELDI mass spectrometry to identify the cleavage product. The present invention also provides for a kit which includes a SELDI sample chip having surface moieties capable of binding to an enzyme cleavage product. | 08-28-2008 |
20100227776 | Rapid Genotyping of SNPs - Embodiments include a universal and generic method for rapidly genotyping essentially any single nucleotide polymorphism (SNP) and or other polymorphism. Various embodiments include procedures for SNP and/or allele analysis that are easy, cheap, highly multiplexable, easily automatable, and lend themselves to high-throughput. Embodiments are broadly applicable for all applications where SNP determinations are useful. | 09-09-2010 |
James Wu, Olmsted Township, OH US
Patent application number | Description | Published |
---|---|---|
20110059343 | HEAT SEALING SEPARATORS FOR NICKEL-ZINC CELLS - Embodiments are described in terms of selective methods of sealing separators and jellyroll electrode assemblies and cells made using such methods. More particularly, methods of selectively heat sealing separators to encapsulate one of two electrodes for nickel-zinc rechargeable cells having jellyroll assemblies are described. Selective heat sealing may be applied to both ends of a jellyroll electrode assembly in order to selectively seal one of two electrodes on each end of the jellyroll. | 03-10-2011 |
20120279056 | HEAT SEALING SEPARATORS FOR NICKEL ZINC CELLS - Embodiments are described in terms of selective methods of sealing separators and jellyroll electrode assemblies and cells made using such methods. More particularly, methods of selectively heat sealing separators to encapsulate one of two electrodes for nickel-zinc rechargeable cells having jellyroll assemblies are described. Selective heat sealing may be applied to both ends of a jellyroll electrode assembly in order to selectively seal one of two electrodes on each end of the jellyroll. | 11-08-2012 |
20140030567 | HEAT SEALING SEPARATORS FOR NICKEL ZINC CELLS - Embodiments are described in terms of selective methods of sealing separators and jellyroll electrode assemblies and cells made using such methods. More particularly, methods of selectively heat sealing separators to encapsulate one of two electrodes for nickel-zinc rechargeable cells having jellyroll assemblies are described. Selective heat sealing may be applied to both ends of a jellyroll electrode assembly in order to selectively seal one of two electrodes on each end of the jellyroll. | 01-30-2014 |
James J. Wu, Olmstead Township, OH US
Patent application number | Description | Published |
---|---|---|
20140157586 | PASTED ZINC ELECTRODE FOR RECHARGEABLE NICKEL-ZINC BATTERIES - Active material for a negative electrode of a rechargeable zinc alkaline electrochemical cell is made with zinc metal particles coated with tin and/or lead. The zinc particles may be coated by adding lead and tin salts to a slurry containing zinc particles, a thickening agent and water. The remaining zinc electrode constituents such as zinc oxide (ZnO), bismuth oxide (Bi | 06-12-2014 |
James X. Wu, North Olmsted, OH US
Patent application number | Description | Published |
---|---|---|
20080213651 | Housing for a Sealed Electrochemical Battery Cell - An electrochemical cell with a collector assembly for sealing the open end of a cell container. The collector assembly includes a retainer and a contact spring with a peripheral flange, each having a central opening therein. A pressure release vent member disposed between the retainer and the peripheral flange of the contact spring seals the openings in the retainer and contact spring under normal conditions and ruptures to release pressure from within the cell when the internal pressure exceeds a predetermined limit. | 09-04-2008 |
20080254343 | Electrochemical cell with thermal current interrupting switch - An electrochemical cell having a current interrupting switch as an internal component of the cell that is thermally responsive and breaks an electrical path within the cell thereby preventing current flow when temperature within the cell is at or above an activating temperature. The switch is reversible and current flow and a closed circuit is re-established when temperature within the cell returns below the activating temperature. | 10-16-2008 |
20090311583 | Closure Assembly with Low Vapor Transmission for Electrochemical Cell - A closure assembly for an electrochemical cell including a container and an end assembly sealing an open end of the container in order to minimize mass or weight loss of the cell due to electrolyte vapor transmission is disclosed. The end assembly is provided with a vent member capable of venting a fluid when the pressure within the cell exceeds a predetermined limit; a contact member operatively in electrical contact with a conductive contact of the end assembly and a current collector of an electrode of the cell; and an insulating, polymeric seal member disposed at least between conductive components of the closure assembly having different polarities. In a preferred embodiment, the seal member has a selected dimensional ratio in order to minimize vapor transmission of the electrolyte through the seal member. | 12-17-2009 |
20100215996 | Closure Assembly for Electrochemical Cells - An end assembly seals a cylindrical electrochemical cell. The assembly includes a positive temperature coefficient (PTC) device and a gasket having a protrusion that cooperates with the end assembly isolates the PTC device from primary axial compression forces present in the closure assembly. In further embodiments of the present invention, the end assembly may be produced by insert molding a seal element about the terminal cover and the gasket itself has an E or F shaped cross section. | 08-26-2010 |
20100248014 | Vapor Transmission Resistant Seal Members for Nonaqueous Electrochemical Cells - A seal member having a thermoplastic body for an electrochemical cell containing a nonaqueous organic solvent electrolyte. In particular, the seal member is preferably one or more of (a) a seal located between a cell container wall and a cell cover and (b) a seal of a vent assembly, more particularly a ball vent assembly. The seal member has a composite construction including one or more vapor transmission barrier layers disposed on a portion of the thermoplastic body. | 09-30-2010 |
20110014507 | Housing for a Sealed Electrochemical Battery Cell - An electrochemical cell with a collector assembly for sealing the open end of a cell container. The collector assembly includes a retainer and a contact spring with a peripheral flange, each having a central opening therein. A pressure release vent member disposed between the retainer and the peripheral flange of the contact spring seals the openings in the retainer and contact spring under normal conditions and ruptures to release pressure from within the cell when the internal pressure exceeds a predetermined limit. | 01-20-2011 |
20110183164 | Housing for a Sealed Electrochemical Cell - An electrochemical cell with a collector assembly for sealing the open end of a cell container. The collector assembly includes a retainer and a contact spring with a peripheral flange, each having a central opening therein. A pressure release vent member disposed between the retainer and the peripheral flange of the contact spring seals the openings in the retainer and contact spring under normal conditions and ruptures to release pressure from within the cell when the internal pressure exceeds a predetermined limit. | 07-28-2011 |
20120151754 | Closure Assembly with Low Vapor Transmission for Electrochemical Cell - A closure assembly for an electrochemical cell including a container and an end assembly sealing an open end of the container in order to minimize mass or weight loss of the cell due to electrolyte vapor transmission is disclosed. The end assembly is provided with a vent member capable of venting a fluid when the pressure within the cell exceeds a predetermined limit; a contact member operatively in electrical contact with a conductive contact of the end assembly and a current collector of an electrode of the cell; and an insulating, polymeric seal member disposed at least between conductive components of the closure assembly having different polarities. In a preferred embodiment, the seal member has a selected dimensional ratio in order to minimize vapor transmission of the electrolyte through the seal member. | 06-21-2012 |
James Xixian Wu, North Olmsted, OH US
Patent application number | Description | Published |
---|---|---|
20100273036 | Lithium-Iron Disulfide Cell Design with Core Reinforcement - A electrochemical cell design, with particular applicability to lithium-iron disulfide batteries, is disclosed. The cell includes a spirally wound electrode assembly with a central core. The core causes uniform expansion within the cathode. The core may also collapse and/or possess a cross sectional shape that differs from the cross sectional shape of the cylindrical container which houses the electrode assembly. | 10-28-2010 |
Jianjun Wu, Olmsted Township, OH US
Patent application number | Description | Published |
---|---|---|
20080241683 | Alkaline electrochemical cell - An alkaline electrochemical cell comprising a negative electrode, wherein the negative electrode includes zinc as an active material and further includes a synergistic combination of a solid zinc oxide and a surfactant. More particularly, the invention discloses an alkaline electrochemical cell that is capable of providing improved service when utilized by high drain devices. | 10-02-2008 |
Junxian Wu, Dublin, OH US
Patent application number | Description | Published |
---|---|---|
20100186897 | PRIMERLESS TWO-PART POLYURETHANE ADHESIVE - A two-part polyurethane adhesive comprising a prepolymer having the reaction product of a non-ionic surfactant and an allophanate modified isocyanate and a curative having a urethane modified high molecular weight polyol, a urethane modified cross-linking compound and a non-urethane modified low molecular weight chain extending compound. The curative has less than 5 equivalent percent total amino and hydroxyl groups having an equivalent weight greater than about 200. The two-part polyurethane adhesive may be used to adhere one or more substrates and can generally be applied without primer or any significant surface preparation. | 07-29-2010 |
Pai-Chuan Wu, Cincinnati, OH US
Patent application number | Description | Published |
---|---|---|
20090029114 | Method and Apparatus for Uniformly Stretching Thermoplastic Film and Products Produced Thereby - Thermoplastic films and laminates are made by extrusion and stretching using differential speed rollers employing a short stretching gap of no more than one inch immediately after the extruded film product is formed. The method and apparatus control the thickness of the stretched film and impart desirable mechanical properties thereto such as film products with a high modulus for handling and suitable tensile for softness. | 01-29-2009 |
20100159776 | MULTILAYER MICROPOROUS FILMS AND COMPOSITES FOR BARRIER PROTECTIVE MATERIALS, AND METHODS - Embodiments of a breathable multilayer microporous film comprise a first outer film layer, a second inner film layer, and a third outer film layer, wherein each film layer comprises at least one pore-forming filler and one thermoplastic polymer. Each film layer is rendered microporous and breathable by stretching each film layer having the pore-forming filler therein, wherein the first and third outer film layers have first and third maximum pore sizes, respectively, and the second inner film layer has a second maximum pore size different than the respective maximum pore sizes of the first and third outer film layers of the multilayer film. The multilayer microporous film passes ASTM F 1671-03 test. | 06-24-2010 |
20140272356 | ELASTOMERIC MATERIALS COMPRISING BIODEGRADABLE AND/OR SUSTAINABLE POLYMERIC COMPONENTS - Elastomeric films and laminates comprising one or more biodegradable and/or sustainable polymers are disclosed. The biodegradable and/or sustainable polymers can be added to the elastomeric film at concentrations up to about 40%, while the film still retains acceptable elastomeric properties. Methods of making elastomeric films or laminates comprising one or more biodegradable and/or sustainable polymers are also disclosed. | 09-18-2014 |
20140272357 | FILM MATERIALS COMPRISING BIODEGRADABLE AND/OR SUSTAINABLE POLYMERIC COMPONENTS - Polymer films comprising blends of biodegradable and/or sustainable polymer are disclosed. These films significantly reduce the amount of petroleum-based polymer in the film, while providing cost savings, processing ease and properties desired by consumers. Polymer films comprising blends of biodegradable and/or sustainable polymers that are microporous and breathable are also disclosed. The polymer films of the present invention may also be laminated to other substrates, such as nonwoven fabrics. | 09-18-2014 |
Qingyu Wu, Orange Village, OH US
Patent application number | Description | Published |
---|---|---|
20110086348 | METHOD FOR ASSESSING HEART DISEASE - A method for assessing heart disease in a subject includes generating an expression profile of at least two or more miRNAs in a sample from the subject. The miRNAs can be selected from the group consisting of hsa-miRNA-1, hsa-miRNA-7, hsa-miRNA-29b, has-miRNA-125b, hsa-miRNA145, hsa-miRNA-181b, hsa-miRNA-214, hsa-miRNA-342, hsa-miRNA-378 and combinations thereof. | 04-14-2011 |
20110160128 | Corin for Treating Obesity and Diabetes - Provided herein are methods of inhibiting agouti or agouti-related protein (AGRP) in a cell or in an individual in need thereof, comprising administering to the cell or the individual an effective amount of an agent that induces corin expression, activity or a combination thereof in the cell or individual. The invention also provides a method of treating obesity in an individual in need thereof comprising administering to the individual an effective amount of an agent that enhances corin expression, activity or a combination thereof in the individual. Further provided is a method of treating diabetes type II in an individual in need thereof comprising administering to the individual an effective amount of an agent that enhances corin expression, activity or a combination thereof in the individual. | 06-30-2011 |
20110306069 | Corin As A Marker For Heart Failure - The invention is a method of assessing whether an individual is afflicted with congestive heart failure (CHF) comprising comparing the level of corin or portion thereof in the individual to the level of corin or portion thereof in a control, wherein a decrease in the level of corin or portion thereof in the individual compared to the level of corin or portion thereof in the control indicates that the individual is afflicted with CHF. The methods described herein can be also be used to determine the severity of CHF in an individual, whether an individual's treatment for CHF is effective and whether an individual is at risk of developing CHF. | 12-15-2011 |
Richard L.c. Wu, Beavercreek, OH US
Patent application number | Description | Published |
---|---|---|
20100277852 | DIELECTRIC COATINGS AND USE IN CAPACITORS - A coated substrate product is described comprising a substrate and a dielectric coating material comprising carbon, hydrogen, silicon, and oxygen. According to the method, the substrate is processed by plasma cleaning the surface and then depositing a dielectric coating by a suitable plasma process. The coating may contain one or more layers. The substrate may be a rigid material or a thin film or foil. The coated products of this invention have superior dielectric material properties and utility as substrates for the manufacture of rolled or parallel plate capacitors with high energy densities. | 11-04-2010 |
20120039017 | Devices Having a Diamond-Like-Carbon Dielectric - A structural capacitor includes a first carbon fiber material layer, a second carbon fiber material layer, and an interlayer dielectric including a diamond-like-carbon material layer. | 02-16-2012 |
Sean Wu, Cleveland, OH US
Patent application number | Description | Published |
---|---|---|
20140288077 | SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY - In one aspect, the invention relates to substituted 4-phenoxyphenol analogs, derivatives thereof, and related compounds, which are useful as inhibitors of proliferating cell nuclear antigen (PCNA); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating hyperproliferative disorders associated with PCNA using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention. | 09-25-2014 |
Shaowen Wu, Cincinnati, OH US
Patent application number | Description | Published |
---|---|---|
20090246343 | Stable Natural Color Process, Products and Use Thereof - A method of preparing colored products from edible materials comprises processing | 10-01-2009 |
20130115252 | Genipin-Rich Material and Its Use - A method of preparing genipin-rich materials from the fruit of | 05-09-2013 |
Shengde Wu, West Chester, OH US
Patent application number | Description | Published |
---|---|---|
20130245076 | PROLYL HYDROXYLASE INHIBITORS AND METHOD OF USE - The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia. | 09-19-2013 |
20140045899 | PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE - The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia. | 02-13-2014 |
20140057892 | PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE - The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD) heart failure, ischemia, and anemia. | 02-27-2014 |
20150119425 | PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE - The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia. | 04-30-2015 |
Shengde Wu, Wester Chester, OH US
Patent application number | Description | Published |
---|---|---|
20100331303 | PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE - The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia. | 12-30-2010 |
20100331374 | PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE - The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia. | 12-30-2010 |
20130203816 | PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE - The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia. | 08-08-2013 |
William Wu, Dublin, OH US
Patent application number | Description | Published |
---|---|---|
20150272183 | METHOD OF PRODUCING AN AROMATISED FOOD OR BEVERAGE PRODUCT - The present invention relates to a method of producing an aromatised food or beverage product, wherein an aroma fraction is obtained from a plant extract, said aroma fraction is being contacted with an oil to remove undesired aroma compounds, and the aroma fraction from which undesired compounds have been removed are combined with a food or beverage composition to produce an aromatised food or beverage product. | 10-01-2015 |
Xianghong Wu, Columbus, OH US
Patent application number | Description | Published |
---|---|---|
20140200186 | SMALL MOLECULE COMPOSITE SURFACES AS INHIBITORS OF PROTEIN-PROTEIN INTERACTIONS - A method of inhibiting a binding event between a target protein and a binding protein, comprising administering to a cell in vitro an effective amount of a non-naturally occurring bifunctional inhibitor molecule including (a) protein binding moiety, and (b) an effector region, wherein the protein binding moiety binds to a blocking protein, and wherein the effector region binds to the target protein in order to bind the target protein and the blocking protein and prevent access of the binding protein to the target protein. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention. | 07-17-2014 |
Xiangyu Wu, Hudson, OH US
Patent application number | Description | Published |
---|---|---|
20090213034 | MULTI-MODALITY MEDICAL IMAGE LAYOUT EDITOR - A medical imaging system comprises one or more displays. A viewer device generates an interactive user interface screen on the display, which viewer device enables a user to simultaneously inspect selected image data of multiple patients or multiple images. A layout editor generates a layout editor user interface in the user interface screen, which layout editor device enables the user to create and/or modify a layout of the selected image data on the display. | 08-27-2009 |
20120320083 | MULTI-MODALITY MEDICAL IMAGE VIEWING - A medical imaging system ( | 12-20-2012 |
20120320093 | MULTI-MODALITY MEDICAL IMAGE VIEWING - A medical imaging system ( | 12-20-2012 |
Xiaohui Wu, Cleveland, OH US
Patent application number | Description | Published |
---|---|---|
20150119706 | BIODEGRADABLE COMPUTED TOMOGRAPHY CONTRAST AGENTS - Biodegradable computed tomography (CT) contrast agents comprising a polyiodinated aryl contrast agent that is crosslinked by an organic disulfide are described herein. The contrast agents can be used to image a tissue region by administering an effective amount of the biodegradable CT contrast agent to a subject, allowing a sufficient amount of time for the biodegradable CT contrast agent to enter the tissue region, and performing x-ray computed tomography imaging of the tissue region of the subject. | 04-30-2015 |
Xiaoming Wu, Strongsville, OH US
Patent application number | Description | Published |
---|---|---|
20080242750 | Polycyclic polymers containing pendant ion conducting moieties - A polymer comprising polycyclic repeating units having recurring ion conducting groups and optional crosslinkable groups is disclosed. The present invention provides the capability of tailoring polymers to impart unique properties to membranes fabricated from the polymers. Membranes comprising the polymers and methods for preparing the membranes and their use in ion conducting membranes, particularly in fuel cells, are also provided. | 10-02-2008 |
20090185003 | HYDROPHOBIC NOZZLE PLATE STRUCTURES FOR MICRO-FLUID EJECTION HEADS - A nozzle plate for a micro-fluid ejection head, a method of making a hydrophobic nozzle plate, and a method for improving the resiliency of a nozzle plate. The nozzle has a photoimageable hydrophobic polycyclic polyolefin layer derived from an epoxy functionalized polynorbornene. | 07-23-2009 |
20090215976 | Photosensitive dielectric resin compositions, films formed therefrom and semiconductor and display devices encompassing such films - Some embodiments in accordance with the present invention relate to norbornene-type polymers and to photosensitive dielectric resin compositions formed therefrom. Other embodiments relate to films formed from such compositions and to devices, such as electrical, electronic and optoelectronic devices, that encompass such films. | 08-27-2009 |
Xueming Wu, Cleveland, OH US
Patent application number | Description | Published |
---|---|---|
20120244070 | FIBRONECTIN TARGETING CONTRAST AGENT - Example systems and methods enhance contrast in MRI images. To facilitate imaging of atherosclerotic plaques, arterial and venous, cardiac, and even tumor tissues and fibrosis, a fibrin-fibronectin complex or disease-related fibronectin specific MRI contrast agent (CLPD) has a specific binding affinity for fibronectin. | 09-27-2012 |
Yeheng Wu, Cleveland, OH US
Patent application number | Description | Published |
---|---|---|
20110188044 | REAL-TIME WIDE-RANGE REFLECTIVE AUTOCORRELATOR - In this invention, multiple pairs of reflective mirror on a high-precision stable rotation stage generate a repetitive wide range delay in a noncolinear intensity autocorrelator. Such autocorrelator is real-time, background-free, dispersion free. It has a continuous long scanning range, from a few femtoseconds to hundreds of picoseconds. | 08-04-2011 |
20110188045 | RANGE ADJUSTABLE REAL-TIME AUTOCORRELATOR - In this invention, two rotating parallel mirrors are used as an optical delay component. The rotating axis and the incident beam are on the same horizontal plane. There is a small angle δ between them. The scan range can be easily adjustable by changing this angle. Using the newly invented method, real-time and range adjustable autocorrelator is realized. | 08-04-2011 |
Yinan Wu, Pataskala, OH US
Patent application number | Description | Published |
---|---|---|
20150283768 | SILICONE OPTICS - Silicone-containing light fixture optics. A method for manufacturing an optical component may include mixing two precursors of silicone, opening a first gate of an optic forming device, moving the silicone mixture from the extrusion machine into the optic forming device, cooling the silicone mixture as it enters the optic forming device, filling a mold within the optic forming device with the silicone mixture, closing the first gate, and heating the silicone mixture in the mold to at least partially cure the silicone. Alternatively, a method for manufacturing an optical component may include depositing a layer of heat cured silicone optical material to an optical structure, arranging one or more at least partially cured silicone optics on the layer of heat cured silicone optical material, and heating the heat cured silicone optical material to permanently adhere the one or more at least partially cured silicone optics to the optical structure. | 10-08-2015 |
Yiying Wu, Columbus, OH US
Patent application number | Description | Published |
---|---|---|
20160006089 | Potassium-Oxygen Batteries Based on Potassium Superoxide - Potassium-oxygen (K—O | 01-07-2016 |
Yong Wu, Cleveland, OH US
Patent application number | Description | Published |
---|---|---|
20120229141 | Optimized RF Shield Design - Radio frequency (RF) shields used with magnetic resonance imaging (MRI) apparatus may experience gradient field induced eddy currents and RF field induced eddy currents. These eddy currents can cause the RF shield to heat up at an undesirable rate. RF shields are designed to have a desired degree of RF shielding and a desired heating attribute. Design goals for RF shields include gradient field transparency and RF field opacity, both of which can be influenced by eddy currents. Example methods identify a gradient field that will induce eddy currents and identify an RF field that will induce eddy currents. If a region on the RF shield is identified where the desired heating attribute will not be achieved, then a pattern of axial cuts and azimuthal cuts can be made in the RF shield to reduce gradient eddy current heating in the RF shield while maintaining desired RF shielding. | 09-13-2012 |
20150212174 | Optimized RF Shield Design - Radio frequency (RF) shields used with magnetic resonance imaging (MRI) apparatus may experience gradient field induced eddy currents and RF field induced eddy currents. These eddy currents can cause the RF shield to heat up at an undesirable rate. RF shields are designed to have a desired degree of RF shielding and a desired heating attribute. Design goals for RF shields include gradient field transparency and RF field opacity, both of which can be influenced by eddy currents. Example methods identify a gradient field that will induce eddy currents and identify an RF field that will induce eddy currents. If a region on the RF shield is identified where the desired heating attribute will not be achieved, then a pattern of axial cuts and azimuthal cuts can be made in the RF shield to reduce gradient eddy current heating in the RF shield while maintaining desired RF shielding. | 07-30-2015 |
Yun Wu, Columbus, OH US
Patent application number | Description | Published |
---|---|---|
20140094383 | Tethered Lipoplex nanoparticle Biochips And Methods Of Use - Disclosed are compositions and methods for the use of lipoplex nanoparticle chips and arrays in the detection of/diagnosis of a disease or condition. | 04-03-2014 |
Yuping Wu, Beachwood, OH US
Patent application number | Description | Published |
---|---|---|
20110124031 | Marker Detection for Characterizing the Risk of Cardiovascular Disease or Complications thereof - The present invention provides methods, systems, devices, and software for determining values for one or more markers in order to characterize a subject's risk of developing cardiovascular disease or experiencing a complication thereof (e.g., within the ensuing one to three years). In certain embodiments, the markers are those derived from a blood sample using a hematology analyzer operably linked to a software application that is configured to compute a risk score for a subject based on the values for the markers detected in the blood sample. | 05-26-2011 |
Yu Tong Wu, Columbus, OH US
Patent application number | Description | Published |
---|---|---|
20150208849 | Infusers and Infusion Devices - An infuser for containing an infusion item includes an a first hollow body, a filter permeable to an infusion component derived from the infusion item, and a first internal volume at least partially defined by the first hollow body and the filter. The first internal volume is dimensioned to receive the infusion item therein. The first hollow body includes an elastomeric material deformable upon application of a deformation force to compress the first internal volume. | 07-30-2015 |
Zhiping Wu, Cleveland, OH US
Patent application number | Description | Published |
---|---|---|
20110201947 | OXIDIZED PARAOXONASE 1 AND PARAOXONASE 1/HDL PARTICLE NUMBER RATIO AS RISK MARKERS FOR CARDIOVASCULAR DISEASE - The present invention provides methods and markers for characterizing a subject's, particularly a human subject risk of having cardiovascular disease. The present invention also provides methods of characterizing a subject's risk of developing cardiovascular disease. In another embodiment, the present invention provides methods for characterizing a subject's risk of experiencing a complication of cardiovascular disease or major adverse cardiac event within 1, 3, or 10 years. In another embodiment, the present invention provides a method for determining whether a subject presenting with chest pain is at risk near term of experiencing a heart attack or other major adverse cardiac event. The present methods are especially useful for identifying those subjects who are in need of highly aggressive CVD therapies as well as those subjects who require no therapies targeted at inhibiting or preventing CVD or complications of CVD. | 08-18-2011 |